Is TEV or CRDL more profitable?

Tervita's return on equity of 0.00% beat Cardiol Therapeutics' return on equity. Company Net Margins Return on Equity Return on Assets Tervita N/A N/A N/A Cardiol Therapeutics N/A -229.16% -54.15%

Which has stronger earnings & valuation, NOT or CRDL?

Noront Resources is trading at a lower price-to-earnings ratio than Cardiol Therapeutics, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Noront Resources N/A N/A N/A -C$0.15 N/A Cardiol Therapeutics N/A N/A -C$42.93M -C$0.39 N/A

Is NOT or CRDL more profitable?

Noront Resources' return on equity of 0.00% beat Cardiol Therapeutics' return on equity. Company Net Margins Return on Equity Return on Assets Noront Resources N/A N/A N/A Cardiol Therapeutics N/A -229.16% -54.15%

Is PYR or CRDL more profitable?

PyroGenesis Canada Inc. (PYR.V)'s return on equity of 0.00% beat Cardiol Therapeutics' return on equity. Company Net Margins Return on Equity Return on Assets PyroGenesis Canada Inc. (PYR.V) N/A N/A N/A Cardiol Therapeutics N/A -229.16% -54.15%

Which has higher valuation & earnings, NVO or CRDL?

Novo Resources Corp. (NVO.V) is trading at a lower price-to-earnings ratio than Cardiol Therapeutics, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Novo Resources Corp. (NVO.V) N/A N/A N/A -C$0.11 N/A Cardiol Therapeutics N/A N/A -C$42.93M -C$0.39 N/A

Is NVO or CRDL more profitable?

Novo Resources Corp. (NVO.V)'s return on equity of 0.00% beat Cardiol Therapeutics' return on equity. Company Net Margins Return on Equity Return on Assets Novo Resources Corp. (NVO.V) N/A N/A N/A Cardiol Therapeutics N/A -229.16% -54.15%

Which has higher earnings & valuation, CRDL or DNA?

Cardiol Therapeutics is trading at a lower price-to-earnings ratio than Dalradian Resources, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cardiol Therapeutics N/A N/A -C$42.93M -C$0.39 N/A Dalradian Resources N/A N/A N/A -C$0.03 N/A

Is CRDL or DNA more profitable?

Dalradian Resources' return on equity of 0.00% beat Cardiol Therapeutics' return on equity. Company Net Margins Return on Equity Return on Assets Cardiol Therapeutics N/A -229.16% -54.15% Dalradian Resources N/A N/A N/A

Cardiol Therapeutics (CRDL) Competitors

C$1.46 0.00 (0.00%)

As of 06/12/2026 04:00 PM Eastern

Compare

CRDL vs. TEV, NOT, PYR, NVO, and DNA

Should you buy Cardiol Therapeutics stock or one of its competitors? MarketBeat compares Cardiol Therapeutics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cardiol Therapeutics include Tervita (TEV), Noront Resources (NOT), PyroGenesis Canada Inc. (PYR.V) (PYR), Novo Resources Corp. (NVO.V) (NVO), and Dalradian Resources (DNA). These companies are all part of the "pharmaceutical products" industry.

How does Cardiol Therapeutics compare to Tervita?

Tervita (TSE:TEV) and Cardiol Therapeutics (TSE:CRDL) are both small-cap pharmaceutical products companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, media sentiment, earnings, analyst recommendations, valuation and profitability.

Tervita has higher revenue and earnings than Cardiol Therapeutics. Cardiol Therapeutics is trading at a lower price-to-earnings ratio than Tervita, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tervita	C$1.36B	0.00	-C$1.04M	-C$0.01	N/A
Cardiol Therapeutics	N/A	N/A	-C$42.93M	-C$0.39	N/A

In the previous week, Tervita's average media sentiment score of 0.00 equaled Cardiol Therapeutics'average media sentiment score.

Company	Overall Sentiment
Tervita	Neutral
Cardiol Therapeutics	Neutral

0.1% of Cardiol Therapeutics shares are held by institutional investors. 4.6% of Cardiol Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Tervita's return on equity of 0.00% beat Cardiol Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tervita	N/A	N/A	N/A
Cardiol Therapeutics	N/A	-229.16%	-54.15%

Summary

Tervita beats Cardiol Therapeutics on 5 of the 8 factors compared between the two stocks.

How does Cardiol Therapeutics compare to Noront Resources?

Noront Resources (CVE:NOT) and Cardiol Therapeutics (TSE:CRDL) are both small-cap pharmaceutical products companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, risk, valuation, profitability and analyst recommendations.

Noront Resources is trading at a lower price-to-earnings ratio than Cardiol Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Noront Resources	N/A	N/A	N/A	-C$0.15	N/A
Cardiol Therapeutics	N/A	N/A	-C$42.93M	-C$0.39	N/A

Noront Resources' return on equity of 0.00% beat Cardiol Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Noront Resources	N/A	N/A	N/A
Cardiol Therapeutics	N/A	-229.16%	-54.15%

0.1% of Cardiol Therapeutics shares are held by institutional investors. 4.6% of Cardiol Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Noront Resources' average media sentiment score of 0.00 equaled Cardiol Therapeutics'average media sentiment score.

Company	Overall Sentiment
Noront Resources	Neutral
Cardiol Therapeutics	Neutral

Summary

Noront Resources and Cardiol Therapeutics tied by winning 3 of the 6 factors compared between the two stocks.

How does Cardiol Therapeutics compare to PyroGenesis Canada Inc. (PYR.V)?

PyroGenesis Canada Inc. (PYR.V) (CVE:PYR) and Cardiol Therapeutics (TSE:CRDL) are both small-cap pharmaceutical products companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, profitability, valuation, earnings, institutional ownership and risk.

In the previous week, PyroGenesis Canada Inc. (PYR.V) had 1 more articles in the media than Cardiol Therapeutics. MarketBeat recorded 1 mentions for PyroGenesis Canada Inc. (PYR.V) and 0 mentions for Cardiol Therapeutics. PyroGenesis Canada Inc. (PYR.V)'s average media sentiment score of 0.00 equaled Cardiol Therapeutics'average media sentiment score.

Company	Overall Sentiment
PyroGenesis Canada Inc. (PYR.V)	Neutral
Cardiol Therapeutics	Neutral

PyroGenesis Canada Inc. (PYR.V)'s return on equity of 0.00% beat Cardiol Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PyroGenesis Canada Inc. (PYR.V)	N/A	N/A	N/A
Cardiol Therapeutics	N/A	-229.16%	-54.15%

PyroGenesis Canada Inc. (PYR.V) has higher revenue and earnings than Cardiol Therapeutics. PyroGenesis Canada Inc. (PYR.V) is trading at a lower price-to-earnings ratio than Cardiol Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PyroGenesis Canada Inc. (PYR.V)	C$6.01M	100.97	-C$3.94M	-C$0.03	N/A
Cardiol Therapeutics	N/A	N/A	-C$42.93M	-C$0.39	N/A

Summary

PyroGenesis Canada Inc. (PYR.V) beats Cardiol Therapeutics on 6 of the 9 factors compared between the two stocks.

How does Cardiol Therapeutics compare to Novo Resources Corp. (NVO.V)?

Novo Resources Corp. (NVO.V) (CVE:NVO) and Cardiol Therapeutics (TSE:CRDL) are both small-cap pharmaceutical products companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, media sentiment, risk, valuation, profitability, analyst recommendations and institutional ownership.

Novo Resources Corp. (NVO.V)'s return on equity of 0.00% beat Cardiol Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Novo Resources Corp. (NVO.V)	N/A	N/A	N/A
Cardiol Therapeutics	N/A	-229.16%	-54.15%

Novo Resources Corp. (NVO.V) is trading at a lower price-to-earnings ratio than Cardiol Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Novo Resources Corp. (NVO.V)	N/A	N/A	N/A	-C$0.11	N/A
Cardiol Therapeutics	N/A	N/A	-C$42.93M	-C$0.39	N/A

In the previous week, Novo Resources Corp. (NVO.V)'s average media sentiment score of 0.00 equaled Cardiol Therapeutics'average media sentiment score.

Company	Overall Sentiment
Novo Resources Corp. (NVO.V)	Neutral
Cardiol Therapeutics	Neutral

0.1% of Cardiol Therapeutics shares are owned by institutional investors. 4.6% of Cardiol Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Novo Resources Corp. (NVO.V) and Cardiol Therapeutics tied by winning 3 of the 6 factors compared between the two stocks.

How does Cardiol Therapeutics compare to Dalradian Resources?

Cardiol Therapeutics (TSE:CRDL) and Dalradian Resources (TSE:DNA) are both small-cap pharmaceutical products companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk, profitability and media sentiment.

0.1% of Cardiol Therapeutics shares are held by institutional investors. 4.6% of Cardiol Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Cardiol Therapeutics is trading at a lower price-to-earnings ratio than Dalradian Resources, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardiol Therapeutics	N/A	N/A	-C$42.93M	-C$0.39	N/A
Dalradian Resources	N/A	N/A	N/A	-C$0.03	N/A

Dalradian Resources' return on equity of 0.00% beat Cardiol Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cardiol Therapeutics	N/A	-229.16%	-54.15%
Dalradian Resources	N/A	N/A	N/A

In the previous week, Cardiol Therapeutics' average media sentiment score of 0.00 equaled Dalradian Resources'average media sentiment score.

Company	Overall Sentiment
Cardiol Therapeutics	Neutral
Dalradian Resources	Neutral

Summary

Cardiol Therapeutics and Dalradian Resources tied by winning 3 of the 6 factors compared between the two stocks.

Get Cardiol Therapeutics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRDL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CRDL vs. The Competition

Export

Metric	Cardiol Therapeutics	Drug Manufacturers Industry	Medical Sector	TSE Exchange
Market Cap	C$168.30M	C$7.16B	C$6.74B	C$13.03B
Dividend Yield	N/A	2.94%	2.67%	6.19%
P/E Ratio	-3.74	5.01	24.21	36.94
Price / Sales	N/A	1,641.46	512.04	10.45
Price / Cash	0.98	10.18	27.48	82.29
Price / Book	6.57	10.44	10.66	4.47
Net Income	-C$42.93M	C$20.27B	C$3.57B	C$299.09M
7 Day Performance	-3.31%	-0.85%	0.58%	0.65%
1 Month Performance	-19.34%	6.93%	1.54%	-0.08%
1 Year Performance	-26.26%	15.90%	25.40%	41.90%

Cardiol Therapeutics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CRDL Cardiol Therapeutics	N/A	C$1.46 flat	N/A	-26.3%	C$168.30M	N/A	N/A	20
TEV Tervita	N/A	N/A	N/A	N/A	C$672.00M	C$1.36B	N/A	36,800	Gap Up
NOT Noront Resources	N/A	C$1.10 -0.5%	N/A	+0.0%	C$612.18M	N/A	N/A	101,700
PYR PyroGenesis Canada Inc. (PYR.V)	N/A	C$3.85 +11.0%	N/A	+0.0%	C$606.96M	C$6.01M	N/A	90	Gap Up
NVO Novo Resources Corp. (NVO.V)	N/A	C$2.38 -0.4%	N/A	+0.0%	C$548.24M	N/A	N/A	54,400

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:CRDL) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cardiol Therapeutics (CRDL) Competitors

CRDL vs. TEV, NOT, PYR, NVO, and DNA

How does Cardiol Therapeutics compare to Tervita?

Summary

How does Cardiol Therapeutics compare to Noront Resources?

Summary

How does Cardiol Therapeutics compare to PyroGenesis Canada Inc. (PYR.V)?

Summary

How does Cardiol Therapeutics compare to Novo Resources Corp. (NVO.V)?

Summary

How does Cardiol Therapeutics compare to Dalradian Resources?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRDL vs. The Competition

Cardiol Therapeutics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cardiol Therapeutics (CRDL) Competitors

CRDL vs. TEV, NOT, PYR, NVO, and DNA

How does Cardiol Therapeutics compare to Tervita?

Which has higher valuation and earnings, TEV or CRDL?

Does the media favor TEV or CRDL?

Do institutionals & insiders believe in TEV or CRDL?

Is TEV or CRDL more profitable?

Summary

How does Cardiol Therapeutics compare to Noront Resources?

Which has stronger earnings & valuation, NOT or CRDL?

Is NOT or CRDL more profitable?

Do insiders and institutionals have more ownership in NOT or CRDL?

Does the media prefer NOT or CRDL?

Summary

How does Cardiol Therapeutics compare to PyroGenesis Canada Inc. (PYR.V)?

Do insiders and institutionals hold more shares of PYR or CRDL?

Does the media prefer PYR or CRDL?

Is PYR or CRDL more profitable?

Which has stronger earnings and valuation, PYR or CRDL?

Summary

How does Cardiol Therapeutics compare to Novo Resources Corp. (NVO.V)?

Is NVO or CRDL more profitable?

Which has higher valuation & earnings, NVO or CRDL?

Does the media prefer NVO or CRDL?

Do institutionals and insiders have more ownership in NVO or CRDL?

Summary

How does Cardiol Therapeutics compare to Dalradian Resources?

Do insiders and institutionals believe in CRDL or DNA?

Which has higher earnings & valuation, CRDL or DNA?

Is CRDL or DNA more profitable?

Does the media prefer CRDL or DNA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRDL vs. The Competition

Cardiol Therapeutics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools